Survey the effect of zinc gluconate on asthma

Phase 3

• Conditions: ??? ??????; allergic asthma.; J45.0

• Registration Number: IRCT20220507054764N1
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 62

Inclusion Criteria

Age 18 to 65 years
Patients with mild to moderate persistent allergic asthma
Body mass index(BMI):20-30 kg/m2
Both genders

Exclusion Criteria

smoking
Pregnancy and lactation
Cardiovascular diseases and other chronic diseases
Use of antioxidant or zinc supplements in the last three months
Not wanting to continue cooperation

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
IL-35. Timepoint: Before and two months after intervention. Method of measurement: ELISA.;TAC. Timepoint: Before and two months after intervention. Method of measurement: ELISA.;FEV1? FVC? FEV1/FVC. Timepoint: Before and two months after intervention. Method of measurement: According to the results of the spirometer-scale:percent.

Secondary Outcome Measures

Name	Time	Method
Serum Zinc. Timepoint: Before and two months after intervention. Method of measurement: Serum Biochemistry Test/ Micro gr/ dl.;Clinical variables and the patient's general status. Timepoint: Before and two months after intervention. Method of measurement: according to the Questionnaires completed by physician superspecialty.;Complete blood cell count and differential count. Timepoint: Before and two months after intervention. Method of measurement: Based on laboratory measurement.